Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106928055B reveals green aspirin synthesis. Choline-based solvents offer cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel visible light method for deuterated aromatics using arylthianthrene salts. Metal-free, high yield, cost-effective for pharma intermediates.
Patent CN117736077B details a safer synthesis route for 1,1,1-trifluoro-2,4-pentanedione offering high purity and supply chain stability for agrochemical manufacturing.
Patent CN112724021A reveals a high-yield ionic liquid method for 4,4'-dinitrodiphenyl ether, offering significant cost reduction and environmental benefits for polyimide manufacturers.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN101891693B reveals a cost-effective 4-step synthesis avoiding expensive sulfonium salts, offering high purity fluconazole intermediates for global supply chains.
Patent CN106543216A reveals high-yield synthesis. Offers supply chain stability and cost efficiency for electronic chemical manufacturing partners.
Patent CN102093237B reveals a novel phase transfer method for gabapentin hydrochloride. This process eliminates inorganic salt waste and enables continuous production for reliable supply chains.
Novel aqueous method for bezafibrate reduces costs and improves safety. Ideal for pharma intermediates supply chain optimization.
Patent CN109053669B reveals a green one-pot synthesis for 4H-benzo[b]pyrans using tannic acid. Discover cost-effective API intermediate manufacturing solutions.
Patent CN115466199B enables oxidant-free esterification. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN115403623A details a metal-free photocatalytic route for 2-pyrrolyl phosphine oxides, offering high yields and reduced costs for pharmaceutical manufacturing.
Patent CN113045479B details a green FeCl3-catalyzed route for 3-hydroxyisoindol-1-ones, offering cost-effective API intermediate manufacturing solutions.
Patent CN101679213A details organocatalytic routes for Aliskiren intermediates, offering cost-effective and scalable manufacturing solutions for pharmaceutical supply chains.
Novel DABCO-catalyzed synthesis of axial chiral fluoreneamine-phenol derivatives offers cost-effective, scalable routes for pharmaceutical intermediates and functional materials.
Patent CN108129308A introduces visible light catalysis for ester synthesis offering green supply chain and cost advantages for pharmaceutical intermediate manufacturing processes globally.
Patent CN117965653A reveals immobilized enzyme method for high-purity agrochemical intermediate manufacturing with reduced solvent burden and enhanced supply chain reliability.
Patent CN101928268A reveals a novel ionic liquid-phosphoric acid catalytic system for synthesizing heterocyclic acetylized compounds, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel photoredox catalysis route for Obitavir reduces steps and metal use. Enhances supply chain reliability for high-purity pharmaceutical intermediates.